By 2020, it is estimated that 2.1 billion people will be presbyopic, and the demand for spectacle independence in this group is growing. This review article provides an overview of the three commercially available corneal inlays for the correction of presbyopia. Safety, efficacy, visual outcomes, and complications are analyzed for all three inlays according to published peer-reviewed data.
CITATION STYLE
Arlt, E. M., Krall, E. M., Moussa, S., Grabner, G., & Dexl, A. K. (2015, January 14). Implantable inlay devices for presbyopia: The evidence to date. Clinical Ophthalmology. Dove Medical Press Ltd. https://doi.org/10.2147/OPTH.S57056
Mendeley helps you to discover research relevant for your work.